Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.410
-0.100 (-2.85%)
Jan 2, 2026, 2:21 PM EST - Market open
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $369.04 million as of January 2, 2026. Its market cap has decreased by -70.58% in one year.
Market Cap
369.04M
Enterprise Value
182.15M
1-Year Change
-70.58%
Ranking
Category
Stock Price
$3.41
Market Cap Chart
Since January 5, 2018, Rocket Pharmaceuticals's market cap has decreased from $413.75M to $369.04M, a decrease of -10.81%. That is a compound annual growth rate of -1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 379.86M | -71.04% |
| Dec 31, 2024 | 1.31B | -51.45% |
| Dec 29, 2023 | 2.70B | 82.43% |
| Dec 30, 2022 | 1.48B | 5.29% |
| Dec 31, 2021 | 1.41B | -57.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |